Zscaler stock dives after weak guidance: Is the crash justified?

Zscaler reported strong Q1 results with revenue of $788M (vs guidance $772M–$774M), operating profit of $172M (vs guidance $166M–$168M) and EPS of $0.96, while ARR topped $3.2B and customers paying >$1M rose to 698 from 491. Management guided Q2 revenue of $797M–$799M (≈23% growth) and full-year revenue of $3.28B–$3.30B with operating profit guided to $172M–$174M; the shares fell >7% in after-hours trading as the forward outlook was softer than investor expectations. Valuation remains rich with a forward P/E near 76 versus a sector median of 22, though rule-of-40 metrics (~45%–49%) underscore robust growth and profitability; technicals show a double-top and near-term downside risk toward ~$250 before a potential rebound.

Analysis

Market structure: ZS’s beat-but-soft-guidance reallocates near-term investor demand away from highest-multiple growth names into either profitable cyber names (PANW, FTNT) or cheaper growth (SNOW), pressuring ZS shares near-term by ~10-20% as momentum funds de-risk. Buyers are likely large enterprise IT budgets (AI security tailwinds) while short-term holders and momentum strategies are the losers; expect increased option-implied vol (+30-60% vs. last week) and a rise in put buying over the next 7–30 days.

Competitive dynamics: Zscaler’s ARR >$3.2B and 698 customers paying >$1M create durable pricing power in secure access/service edges, but customer concentration (large-account growth) creates single-client churn risk; Palo Alto and Fortinet can defend share via bundling, so ZS must sustain ~23% revenue growth to justify P/E~76. If ZS maintains rule-of-40 ~45–49%, market eventually re-rates; failure to accelerate from 23% would shift multiples toward sector median within 12–24 months.

Risk assessment: Tail-risks include a large enterprise churn event (>3% ARR loss) or an AI-security competitor win that reduces large-account additions—either could cut growth to <15% and collapse valuation 30–50%. Near-term (days–weeks) technical downside to $250 (neckline) is likely; medium-term (3–12 months) catalysts are customer renewals, macro IT spend, and competitor earnings (PANW, FTNT, SNOW) that can flip sentiment.

Trade and contrarian angle: The market likely overreacted given ZS’s conservative history—management has tended to outpace guidance — so a staged dip-buy strategy is sensible. However, don’t ignore technicals: expect a retest of $250 then a recovery to prior resistance $317 over 3–9 months if ARR and gross margins hold; short squeeze risk exists if volatility compresses and longs rebuild position sizes.

Key Decisions for Investors

• Establish a staged long in ZS totaling 2–3% of portfolio equity: tranche sizes 0.75% at $270, 1.0% at $255, final 0.25–1.0% at $245. Set hard stop at $235 and target take-profits at $317 (partial 50%) and $360 (remaining) over a 3–12 month horizon, adjusting if ARR guidance or large-account churn signals change.
• Implement a hedged options pair: buy ZS Jan 2026 300 LEAP calls (cost-limited exposure ≈1–2% notional) while selling 1–3 month 10% out-of-the-money put spreads (e.g., buy 230–250 put spread) to monetize elevated near-term IV and finance long-dated upside, expecting mean reversion to resistance within 6–12 months.
• Relative-value pair trade: long ZS (as above) and short 1% notional of an overvalued growth peer with weaker profitability (e.g., SNOW) or a crowded AI infrastructure name — calibrate short entry if that name trades <15x forward revenue or exhibits higher downside beta; rebalance after next quarterly earnings (within 60–120 days).
• Overweight defensive/profitable cyber: rotate 1–3% from cyclicals into PANW and FTNT (buy in 2 equal tranches: now and on any further 8–12% sector pullback). These should act as lower-volatility exposure to cyber secular growth while ZS digests guidance execution risks.